Progenics

From Verify.Wiki
Jump to: navigation, search

Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. Progenics has two commercial products, RELISTOR® (methylnaltrexone bromide) for opioid-induced constipation, which is partnered with Bausch Health Companies, Inc.; and AZEDRA, for the treatment of unresectable, locally advanced or metastatic pheochromocytoma or paraganglioma (rare neuroendocrine tumors of neural crest origin) who require systemic anticancer therapy.

QuickUpload1048 20170727120829.jpg
http://www.progenics.com
Type Public
Founded 1988
Headquarters New York, New York
Number of employees 51-200 employees


History

Controversies

Top 5 Recent Tweets

DateAuthorComment
November 16, 2022JacobPliethCFO summary of $LNTH evolution over 60yrs: established in microbubble & spect imaging biz. Progenics takeover took… https://t.co/ch8ct1ui1T
November 14, 2022ivythornes1💥Derma Progenics : Nobody Tells You The Truth https://t.co/RBpmESHkDA via @YouTube


Top 5 Recent News Headlines

Top 5 Lifetime Tweets

Top 5 Lifetime News Headlines

Verification history